Josh Kaufman's practice focuses on capital markets transactions, primarily in the life sciences and technology verticals. He represents US and foreign private issuers and underwriters in a wide variety of public offerings and private placements. Josh has advised clients on more than 200 financing transactions with an aggregate value in excess of $100 billion. He also counsels clients with respect to public company and corporate governance matters; general corporate and commercial matters; mergers & acquisitions, de-SPACs and other strategic transactions; and dealings with securityholders, securities exchanges and regulatory bodies.
Download full bio